Skip to main content
Clinical Trials/NCT03631797
NCT03631797
Completed
Not Applicable

L'Etude préopératoire de la Microcirculation Pour la prédiction Des Complications après Une Chirurgie Cardiaque Sous Circulation Extracorporelle.

University Hospital, Angers1 site in 1 country60 target enrollmentJanuary 14, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Extracorporeal Circulation; Complications
Sponsor
University Hospital, Angers
Enrollment
60
Locations
1
Primary Endpoint
Postoperative complication
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

Cardiac surgery is responsible for many complications. Microcirculation is involved in many of them. The objective of this study is to prospectively investigate the prognostic value of preoperative microcirculatory assessment in patients scheduled for cardiac surgery with CPB for the occurrence of postoperative complications.

Microvascular dysfunction is suspected of being involved in postoperative psycho-cognitive decline. The influence of microcirculation on the evolution of psycho-cognitive assessment is also analyzed in this study.

Detailed Description

Eligible patients are included during the preoperative assessment. Written consent is signed after complete explanation of the protocol. Patient characteristics as treatments, medical history, and EuroSCORE II are registered. Moreover, intraoperative data is collected. Psycho-cognitive and functional evaluation is made preoperatively. Microcirculation is evaluated for each patient before surgery. Complications are registered at the end of hospital stay. Psycho-cognitive and functional evaluation is repeated by call 30 days after the surgery.

Registry
clinicaltrials.gov
Start Date
January 14, 2019
End Date
April 26, 2019
Last Updated
3 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
University Hospital, Angers
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Valvular ou coronary elective cardiac surgery under cardiopulmonary bypass
  • Fair skin phototype
  • Ability to understand the study goal, no dementia.
  • Affiliation to the French National Healthcare System
  • Voluntary patients who have signed an informed consent

Exclusion Criteria

  • Emergency surgery
  • Multiple procedures, combined surgery (valvular and coronary)
  • Single aortic surgery
  • Patient already included in the study (second surgery)
  • Patients protected by decision of law

Outcomes

Primary Outcomes

Postoperative complication

Time Frame: 30 postoperative days

Composite criteria and include microcirculation postoperative complications: * Late surgical re-intervention (greater than 12 hours) for evacuation of pericardial effusion (seeps), * Surgical wound disunion or surgical site infection, * Organ failure: SOFA score greater than 2 at 48h, * Postoperative confusion: assessed using the Confusion Assessment Method (CAM) or the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU), * Acute renal failure ≥ stage 2 according to the KDIGO classification, * Acute lung injury defined as PaO2 \<55mmHg in ambient air, PaO2 / FiO2 ratio \<250 or Pulse Oxygen Saturation (SpO2) \<90% and need for oxygen therapy, * Atrial fibrillation (excluding patients with permanent Atrial Fibrillation preoperatively), * Hepatocellular injury (Cytolysis \> 10N, Prothrombin rate and Factor V decreased \< 60%).

Secondary Outcomes

  • Cognitive evolution(Inclusion and 30 days after surgery)
  • Functional evolution(Inclusion and 30 days after surgery)
  • Mood evolution(Inclusion and 30 days after surgery)
  • Evolution of degree of disability(Inclusion and 30 days after surgery)

Study Sites (1)

Loading locations...

Similar Trials